ABEV Ambev posts narrow Q4 2025 earnings beat shares fall 204 percent on muted investor sentiment XHR Xenia delivers 131 percent Q4 2025 EPS beat even as shares tick lower in muted postearnings trading Is AbbVie ABBV stock losing upward momentum Q4 2025 EPS Exceeds Expectations